Genome Institute of Singapore Release: Daughter Cells Generated From Embryonic Stem Cells May Provide A Safer Way To Develop Clinical Stem Cell Therapies
Scientists at the Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) have found a way of manipulating embryonic stem cells (ESCs) that could allow stem cells to be produced in a safe and efficient manner for use in clinical treatments.